Decision of the EEA joint Committee No 289/2021 of 29 October 2021 amending Annex... (22024D0537)
EU - Internationale Abkommen
2024/537
29.2.2024

DECISION OF THE EEA JOINT COMMITTEE No 289/2021

of 29 October 2021

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/537]

THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2021/345 of 25 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product types 2, 3, 4 and 5  ( 1 ) is to be incorporated into the EEA Agreement.
(2) Commission Implementing Regulation (EU) 2021/347 of 25 February 2021 approving active chlorine released from hypochlorous acid as an active substance for use in biocidal products of product-types 2, 3, 4 and 5  ( 2 ) is to be incorporated into the EEA Agreement.
(3) Commission Implementing Regulation (EU) 2021/348 of 25 February 2021 approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10  ( 3 ) is to be incorporated into the EEA Agreement.
(4) Commission Implementing Decision (EU) 2021/327 of 23 February 2021 postponing the expiry date of approval of metofluthrin for use in biocidal products of product-type 18  ( 4 ) is to be incorporated into the EEA Agreement.
(5) Commission Implementing Decision (EU) 2021/333 of 24 February 2021 postponing the expiry date of approval of alphachloralose for use in biocidal products of product-type 14  ( 5 ) is to be incorporated into the EEA Agreement.
(6) Commission Implementing Decision (EU) 2021/354 of 25 February 2021 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8  ( 6 ) is to be incorporated into the EEA Agreement.
(7) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzu (Commission Implementing Regulation (EU) 2020/1763) of Chapter XV of Annex II to the EEA Agreement:
‘12zzzzzzv.
32021 R 0345 : Commission Implementing Regulation (EU) 2021/345 of 25 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product types 2, 3, 4 and 5 ( OJ L 68, 26.2.2021, p. 163 ).
12zzzzzzw.
32021 R 0347 : Commission Implementing Regulation (EU) 2021/347 of 25 February 2021 approving active chlorine released from hypochlorous acid as an active substance for use in biocidal products of product-types 2, 3, 4 and 5 ( OJ L 68, 26.2.2021, p. 170 ).
12zzzzzzx.
32021 R 0348 : Commission Implementing Regulation (EU) 2021/348 of 25 February 2021 approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10 ( OJ L 68, 26.2.2021, p. 174 ).
12zzzzzzy.
32021 D 0327 : Commission Implementing Decision (EU) 2021/327 of 23 February 2021 postponing the expiry date of approval of metofluthrin for use in biocidal products of product-type 18 ( OJ L 64, 24.2.2021, p. 10 ).
12zzzzzzz.
32021 D 0333 : Commission Implementing Decision (EU) 2021/333 of 24 February 2021 postponing the expiry date of approval of alphachloralose for use in biocidal products of product-type 14 ( OJ L 65, 25.2.2021, p. 58 ).
12zzzzzzza.
32021 D 0354 : Commission Implementing Decision (EU) 2021/354 of 25 February 2021 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8 ( OJ L 68, 26.2.2021, p. 219 ).’

Article 2

The texts of Implementing Regulations (EU) 2021/345, (EU) 2021/347 and (EU) 2021/348 and Implementing Decisions (EU) 2021/327, (EU) 2021/333 and (EU) 2021/354 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 30 October 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
Done at Brussels, 29 October 2021.
For the EEA Joint Committee
The President
Rolf Einar FIFE
( 1 )    OJ L 68, 26.2.2021, p. 163 .
( 2 )    OJ L 68, 26.2.2021, p. 170 .
( 3 )    OJ L 68, 26.2.2021, p. 174 .
( 4 )    OJ L 64, 24.2.2021, p. 10 .
( 5 )    OJ L 65, 25.2.2021, p. 58 .
( 6 )    OJ L 68, 26.2.2021, p. 219 .
( *1 )   No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2024/537/oj
ISSN 1977-0677 (electronic edition)
Markierungen
Leseansicht